Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /1796
chevron_leftBack
GeneFerm Biotechnology Co., Ltd. logo

GeneFerm Biotechnology Co., Ltd.

1796
TPEX: 1796 Delayed
38.00TWD -0.3%
1.20 USD
As of 6 June 2026, GeneFerm Biotechnology Co., Ltd. has a market cap of $50.22M USD, ranking #30567 globally and #1840 in Taiwan. It ranks #2761 in the Healthcare sector, and #159 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
30567
Country Rank
1840
Sector Rank
2761
Industry Rank
159
Key Stats
Market Cap
$50.22MUSD
1.58B TWD
Enterprise Value
$51.39MUSD
1.62B TWD
Revenue (TTM)
$21.52MUSD
677.1M TWD
EBITDA (TTM)
$3.59MUSD
113.48M TWD
Net Income (TTM)
$917.51KUSD
28.86M TWD
EBITDA Margin
17%
Profit Margin
4.3%
PE Ratio
54.7
PS Ratio
2.3
PB Ratio
1.9
EV/EBITDA
13.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jinde Jin open_in_new
Employees
144
Founded
1999
Website
geneferm.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% -5.9% 6.9% -16% -22% -16%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
1796
金穎生物科技股份有限公司
ISIN: TW0001796001
Shares Out.:
41.46M1
TV:
SA:
YF:
GF:
BA:
MS:
38.00 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About GeneFerm Biotechnology Co., Ltd.

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company provides microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as well as probiotics and peptide ingredients. It also provides private label supplements; and microbial fermentation toll manufacturing services. The company was founded in 1999 and is headquartered in Tainan City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)
Name
Market Cap diff.
PE
$1.68B
52.95B TWD
3K%
17.9
1707
$536.85M
16.89B TWD
969%
14.0
$476.38M
14.99B TWD
849%
36.5
8436
$415.07M
13.06B TWD
727%
13.7
4128
$291.68M
9.18B TWD
481%
-
7832
$244.3M
7.69B TWD
387%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
75K%
24.2
$29.56B
59K%
-
$15.86B
107.34B CNY
31K%
16.0
CIPLA
$11.12B
1.06T INR
22K%
23.4
LUPIN
$11.0B
1.05T INR
22K%
22.7
$9.1B
61.6B CNY
18K%
80.6
chevron_leftBack